Recurrent Adult Immunoblastic Large Cell Lymphoma Active Not Recruiting Phase 2 Trials for DB00073 (Rituximab)

DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT01044745Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment
NCT00119392Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTreatment